GT Biopharma (GTBP) Technical Analysis
As of 2026-09-11, GTBP last traded at 8.61 USD (+43.98% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: 7.03 USD support below, no clear near resistance above. 14-day RSI is 54.1 (neutral).
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
Is GTBP in an uptrend or downtrend?
GT Biopharma is in a range — insufficient history for 200-DMA.
| Last close | 8.61 USD (+43.98%) |
|---|---|
| 20-day average | 7.234 USD |
| 50-day average | n/a |
| 200-day average | n/a |
Key support and resistance levels for GTBP
Derived from swing pivots over the last 37 sessions:
No clearly-defined swing levels in the current range.
| Level | Type | Strength | Touches |
|---|---|---|---|
| 7.03 USD | Support | Minor | 1 |
| 6.85 USD | Support | Minor | 1 |
GTBP 52-week range, momentum and volatility
| 52-week high | 13.94 USD (38.2% below) |
|---|---|
| 52-week low | 4.91 USD (75.4% above) |
| 14-day RSI | 54.1 (Neutral) |
| 14-day ATR | 0.802 USD (9.32% of price, High volatility) |
Related research pages
Frequently asked questions
Is GT Biopharma (GTBP) in an uptrend or downtrend?
As of 2026-09-11, GTBP is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 8.61 USD vs 50-day average n/a and 200-day average n/a.
What are the key support and resistance levels for GTBP?
Nearest support is around 7.03 USD (minor, 1 touch). No clear resistance above price in range. Levels are derived from swing pivots over the last ~200 sessions.
What is GTBP's 52-week high and low?
Over the last 52 weeks, GTBP traded between 4.91 USD and 13.94 USD. It is currently 38.2% below its 52-week high.
Is GTBP overbought or oversold?
The 14-day RSI is 54.1 — in a neutral 30–70 range. Momentum reads as neutral.
How volatile is GTBP?
Its 14-day Average True Range is 0.802 (9.32% of price) — high volatility relative to price.